Pinotbio

Provider of therapeutics solution for cancer, glaucoma and other diseases

placeSuwon-si, Gyeonggi-do, South Korea calendar_todayFounded 2017 groups9 employees language pinotbio.com

Registered entities

Investor mix

14 investors on record; lead investors include LOTTE BIOLOGICS.

Investor typeCountShare
Venture capital643%
Private equity643%
Other / undisclosed214%
Coming soon